Yoichi Koizumi
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoichi Koizumi.
The American Journal of Medicine | 1979
Ichiro Komiya; Yoichi Koizumi; Ryoji Kobayashi; Masanobu Kotani; Takashi Yamada; Yuzo Maruyama
Hypertension, hypokalemia, suppressed plasma renin activity and increased plasma aldosterone were found in a middle-aged woman. Following removal of the tumor in the left adrenal gland these abnormalities disappeared. Concurrently, however, the plasma cortisol level did not show normal diurnal change, although the value at 6 A.M. was within the normal range. Administration of 2 mg dexamethasone failed to depress the plasma cortisol level and urinary 17-OHCS concentrations. Postoperatively, plasma cortisol and urinary 17-OHCS were below normal. Histologic examination of the tumor indicated the presence of two types of adenoma cells; one was a large watery clear cell with rich lipid and possibly with aldosterone secretion and the other was an acidophilic cell with poor lipid and possibly with cortisol secretion. It is suggested that, in addition to oversecretion of aldosterone, the tumor autonomously secreted cortisol, although the amount of cortisol secreted was not large enough to produce typical Cushings syndrome.
Diabetes Care | 1985
Ichiro Komiya; Takashi Yamada; Akira Sato; Yoichi Koizumi; Takeshi Aoki
The mechanism of glucose intolerance in thyrotoxicosis was investigated in 119 patients with Gravess disease with careful consideration of the age-related deterioration of glucose tolerance. Before and after treatment of thyrotoxicosis with antithyroid drug, changes of blood glucose (BG) and serum immunoreactive insulin (IRI) in response to 50 g oral glucose tolerance test (OGTT) and insulin binding to red blood cell (RBC) were evaluated. In control subjects, the ΣIRI/ΣBG ratio after 50-g OGTT decreased progressively with age without significant change in absolute ΣIRI value, suggesting the occurrence of age-related insulin resistance. Glucose intolerance was much more apparent in hyperthyroid patients because of age-related relative decrease of insulin secretion. Such a decrease of insulin secretion was not found in age-matched postgastrectomy patients with a similar degree of hyperglycemia, however. Maximal binding of labeled insulin and number of insulin receptors of RBC were decreased in old patients but binding affinity was unchanged. Elevation of BG was partially suppressed when serum thyroxine (T4) and triiodothyronine (T3) were reduced to moderately supernormal levels, whereas ΣBG, ΣIRI, ΣIRI/ΣBG ratio, and insulin binding to RBC were all returned to normal when normal serum thyroid hormone concentration was maintained. Our data indicate that insufficient insulin secretion and reduced insulin action at the target cell are responsible, at least in large part, for age-related glucose intolerance in hyperthyroid patients.
Geriatrics & Gerontology International | 2006
Kiyoshi Hashizume; Satoru Suzuki; Teiji Takeda; Satoshi Shigematsu; Kazuo Ichikawa; Yoichi Koizumi
Endocrinological functions of aging subjects deviate from those of young subjects during the aging process. There are two types of deviation expressed as: (i) an adaptation to the aging process; and (ii) an acceleration of aging. The former includes hyperparathyroidism, hyperglycemia and hyperinsulinemia. The latter includes growth hormone resistance and low‐T3 syndrome. Excess adaptation promotes the metabolic syndrome. Excess acceleration of aging easily leads subjects to mental disorder and death. In order to prevent subjects from both excess adaptation to and excess acceleration of aging, endocrinological intervention is required.
Internal Medicine | 2018
Yuya Kobayashi; Jun Tsuyuzaki; Yoichi Koizumi
A 51-year-old Japanese woman without any particular medical and family history presented with the sudden onset of intermittent numbness of the right hand fifth finger. Computed tomography of the head revealed extensive calcification in the bilateral globi pallidi, dentate nuclei, and subcortical white matter (Picture 1-3). However, she did not have any neurological manifestations, such as movement disorder, extrapyramidal signs and cerebellar dysfunction. Trousseau’s sign was observed without hyperventilation and it caused her intermittent numbness. Her serum calcium level was 6.1 (normal 8.7-10.3) mg/dL. Serum phosphate, magnesium, and 1, 25-(OH)2 vitamin D levels and thyroid and renal function were normal; intact-parathyroid hormone (PTH) level was 193 (normal 10-65) pg/mL. A diagnosis of pseudohypoparathyroidism was thus made. There was no calcification observed at any other sites characteristic for this disease. She had no physical characteristics typical of Albright’s hereditary osteodystrophy and she was classified as type 1b. Her serum calcium levels thereafter normalized and the symptoms disappeared following alfacalcidol treatment. Pseudo-
The Journal of Clinical Endocrinology and Metabolism | 1984
Nobuyuki Takasu; Tetsuo Mori; Yoichi Koizumi; Shin Takeuchi; Takashi Yamada
Journal of the American Geriatrics Society | 1994
Takashi Yamada; Toru Aizawa; Yoichi Koizumi; Ichiro Komiya; Kazuo Ichikawa; Kiyoshi Hashizume
The Journal of Clinical Endocrinology and Metabolism | 1988
Manabu Murakami; Yoichi Koizumi; Toru Aizawa; Takashi Yamada; Yoshio Takahashi; Takuji Watanabe; Kyuji Kamoi
Endocrine Journal | 2007
Kiyoshi Hashizume; Satoru Suzuki; Ai Komatsu; Kunihide Hiramatsu; Junichiro Mori; Masanori Yamazaki; Teiji Takeda; Tomoko Kakizawa; Takahide Miyamoto; Yoichi Koizumi; Kazuo Ichikawa
Endocrine Journal | 2002
Takeshi Inagaki; Yutaka Nishii; Naomi Suzuki; Satoru Suzuki; Yoichi Koizumi; Toru Aizawa; Kiyoshi Hashizume
Cancer Research | 1978
Masanobu Kotani; Yoichi Koizumi; Takashi Yamada; Akiko Kawasaki; Taro Akabane